About LogicBio Therapeutics, Inc. (adapted from LogicBio Therapeutics, Inc. prospectus):
They are a genome editing company focused on developing medicines to durably treat rare diseases in patients with significant unmet medical need using GeneRide, our proprietary technology platform.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.